ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $219.58 -0.17%
EPS Growth %: +5.5%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, $0.15 better than the analyst estimate of $1.36. Revenue for the quarter came in at $904 million versus the consensus estimate of $860.89 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
- Adobe beats Q3 targets, but soft Q4 sales guidance triggers dip
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
